The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
The proteomic skin profile of moderate-to-severe atopic dermatitis patients shows an inflammatory signature
Abstract
BACKGROUND Moderate-to-severe atopic dermatitis/AD is increasingly recognized as a systemic disease, largely due to proteomic blood studies. There are growing efforts to develop AD biomarkers utilizing minimal tissues. OBJECTIVE To characterize the AD skin proteomic signature and its relationship with the blood proteome, and genomic skin profile in the same individuals. METHODS We evaluated lesional and non-lesional biopsies and blood from moderate-to-severe AD (n=20) and healthy (n=28) individuals using OLINK proteomics (utilizing 10μg/10μL for skin and blood) and RNAseq (skin). RESULTS The AD skin proteome demonstrated significant upregulation in lesional and even in non-lesional skin compared to controls in inflammatory markers (MMP12; Th2/IL1RL1/IL-33R, IL-13, CCL17; Th1/ CXCL10; Th17/Th22/PI3, CCL20, S100A12), and in cardiovascular-associated proteins (SELE, MMPs, PGF, MPO, FABP4, VEGFA; FDR<0.05). Skin proteins demonstrated much higher and significant upregulations (vs. controls) compared to blood, suggesting a skin source for the inflammatory/cardiovascular profile. Gene and protein expressions were correlated (r=0.410, P<0.001), with commonly upregulated inflammatory and cardiovascular-risk products, suggesting protein translation in skin. LIMITATIONS Our analysis was limited to 354 proteins. CONCLUSIONS The AD skin proteome shows an inflammatory and cardiovascular signature even in non-lesional skin, emphasizing the need for proactive treatment. Skin proteomics presents a sensitive option for biomarker monitoring.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GSVA: gene set variation analysis for microarray and RNA-Seq data
Hänzelmann, S., Castelo, R., & Guinney, J. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-7 · Cited by 15,440
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
voom: precision weights unlock linear model analysis tools for RNA-seq read counts
Law, C. W., Chen, Y., Shi, W., & Smyth, G. K. (2014) · Genome Biology · doi:10.1186/gb-2014-15-2-r29 · Cited by 6,155
Assarsson, E., Lundberg, M., Holmquist, G., Björkesten, J., Bucht Thorsen, S., Ekman, D., Eriksson, A., Rennel Dickens, E., Ohlsson, S., Edfeldt, G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095192 · Cited by 1,874
Comorbidities and the impact of atopic dermatitis
Silverberg, J. I. (2019) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2019.04.020 · Cited by 431
Early-onset pediatric atopic dermatitis is TH2 but also TH17 polarized in skin
Esaki, H., Brunner, P. M., Renert-Yuval, Y., Czarnowicki, T., Huynh, T., Tran, G., Lyon, S., Rodriguez, G., Immaneni, S., Johnson, D. B., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.07.013 · Cited by 428
Self-citationBrunner, P. M., He, H., Pavel, A. B., Czarnowicki, T., Lefferdink, R., Erickson, T., Canter, T., Puar, N., Rangel, S. M., Malik, K., et al. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2019.04.036 · Cited by 109
Self-citation
Cited by
Wollenberg, A., Blauvelt, A., Guttman‐Yassky, E., Worm, M., Lynde, C., Lacour, J. ‐., Spelman, L., Katoh, N., Saeki, H., Poulin, Y., et al. (2021) · British Journal of Dermatology · doi:10.1111/bjd.19574 · Cited by 638
Self-citationAbrocitinib versus Placebo or Dupilumab for Atopic Dermatitis
Bieber, T., Simpson, E. L., Silverberg, J. I., Thaçi, D., Paul, C., Pink, A. E., Kataoka, Y., Chu, C.-Y., DiBonaventura, M., Rojo, R., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2019380 · Cited by 476
Biomarkers in atopic dermatitis—a review on behalf of the International Eczema Council
Renert-Yuval, Y., Thyssen, J. P., Bissonnette, R., Bieber, T., Kabashima, K., Hijnen, D., & Guttman-Yassky, E. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.01.013 · Cited by 350
Self-citationUpdate on the Pathogenesis and Therapy of Atopic Dermatitis
Li, H., Zhang, Z., Zhang, H., Guo, Y., & Yao, Z. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08880-3 · Cited by 277
Cytokine-Mediated Crosstalk Between Keratinocytes and T Cells in Atopic Dermatitis
Humeau, M., Boniface, K., & Bodet, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.801579 · Cited by 75
Metadata
- Authors
- Pavel, A. B., Zhou, L., Diaz, A., Ungar, B., Dan, J., He, H., Estrada, Y. D., Xu, H., Fernandes, M., Renert-Yuval, Y., Krueger, J. G., & Guttman-Yassky, E.
- Venue
- Journal of the American Academy of Dermatology
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 82
- Issue
- 3
- Pages
- 690-699
- ISSN
- 0190-9622 (ISSN-L)
- OpenAlex
- W2981957052
- Cited by
- 168
- References
- 7
- FWCI
- 14.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The proteomic skin profile of moderate-to-severe atopic dermatitis patients shows an inflammatory signature. https://app.cochat.ai/papers/10.1016/j.jaad.2019.10.039
- The paper
- Pavel, A. B., Zhou, L., Diaz, A., Ungar, B., Dan, J., He, H., Estrada, Y. D., Xu, H., Fernandes, M., Renert-Yuval, Y., Krueger, J. G., & Guttman-Yassky, E. (2020). The proteomic skin profile of moderate-to-severe atopic dermatitis patients shows an inflammatory signature. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2019.10.039
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.